Progress in Optical Methods for the Detection of Two Core Blood Biomarkers of Alzheimer’s Disease: Amyloid-Beta and Tau Proteins
Biosensors · 06.08.2026 · 16 (8) · 427
DOI: 10.3390/bios16080427 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 06.08.2026. Verfasst von Ning Xia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Henan Province of Key Laboratory of New Optoelectronic Functional Materials, College of Chemistry and Chemical Engineering, Anyang Normal University,…. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, tau Proteins, Biosensing Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Youth Fund of Natural Science Foundation of Henan Province.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide. Early diagnosis of AD is crucial for delaying disease progression and improving patients’ quality of life. Blood biomarkers, particularly amyloid-beta (Aβ) and Tau proteins along with their phosphorylated isoforms, show advantages such as convenient sampling, minimal invasiveness, and excellent repeatability. However, the extremely low concentrations of AD biomarkers in blood impose stringent requirements on the sensitivity, specificity, and anti-interference capability of detection methods. Optical methods provide promising analytical platforms to address these challenges in view of their intrinsic merits of high sensitivity and selectivity; rapid response; and potential for miniaturization. This review systematically summarizes the latest advances in optical methods for the detection of the two core AD blood biomarkers (Aβ and Tau), covering techniques such as colorimetry, fluorescence, chemiluminescence, surface plasmon resonance (SPR), and surface-enhanced Raman scattering (SERS). The sensing principles, design strategies, and analytical performances of these methods are discussed, with special emphasis on different signal amplification strategies. In addition, several challenges and future prospects are provided with a primary focus on single-molecule detection, insufficient sensitivity and stability, lack of validation with large clinical cohorts, and absence of standardization. This review aims to provide researchers with guidance for the rational development of high-performance optical methods to achieve early diagnosis of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Province of Key Laboratory of New Optoelectronic Functional Materials, College of Chemistry and Chemical Engineering, Anyang Normal University, Anyang 455000, China.
ORCID-Profile: Ning Xia
Förderung
- Project of Youth Fund of Natural Science Foundation of Henan Province
Zitieren
APA
Xia, N., Gao, F., & Zheng, C. (2026). Progress in Optical Methods for the Detection of Two Core Blood Biomarkers of Alzheimer’s Disease: Amyloid-Beta and Tau Proteins. Biosensors, 16(8), 427. https://doi.org/10.3390/bios16080427
Vancouver
Xia N, Gao F, Zheng C. Progress in Optical Methods for the Detection of Two Core Blood Biomarkers of Alzheimer’s Disease: Amyloid-Beta and Tau Proteins. Biosensors. 2026;16(8):427. doi:10.3390/bios16080427
BibTeX
@article{Xia2026,
author = {Xia, Ning and Gao, Fengli and Zheng, Chuye},
title = {Progress in Optical Methods for the Detection of Two Core Blood Biomarkers of Alzheimer’s Disease: Amyloid-Beta and Tau Proteins},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {8},
pages = {427},
doi = {10.3390/bios16080427}
}
EUVIMED